SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Tel Aviv Stock Exchange CEO offered $1.65 million retention package as his stake reaches $145 million

Amdocs server farm was allegedly chosen as target in planned terror attack

Serbia opens Israeli drone factory as defense ties with Elbit deepen

Israel won’t force Chevron out of Tamar or Leviathan

Buzz

Most popular

Daily

Weekly

1

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

2

The man who helped build Palo Alto’s Cortex is leaving the company

3

Oracle is expanding layoffs but its new CFO says “don’t do more with less”

4

Sayeret Matkal veterans raise $22 million to teach the world English with AI

5

Five months old, Noetive raises $41 million Seed to build AI for the physical economy

Tourette Syndrome

2 stories about Tourette Syndrome

המרכז הלוגיסטי של חברת טבע בשוהם

Teva reaches its highest level since 2017 as investors embrace its transformation

Shares have risen about 20% in August, lifting the Israeli drugmaker's market value to $43.5 billion as innovative medicines and a growing pipeline reshape its investment story.

An Israeli Company Wants to Treat Tourette Syndrome With Cannabis

09.04.18|Lilach Baumer

Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday